Pradžia › 1 tipo cukrinis diabetas › Washington
1 tipo cukrinis diabetas klinikiniai tyrimai Washington
20 tyrimai dėl 1 tipo cukrinis diabetas ieško dalyvių vietose Washington.
Miestai Washington
Oficialus tyrimo tekstas (anglų kalba)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 8 iki 35 · Visoms lytims · Atnaujinta 2026-09-18 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Renkami dalyviai2 fazė
Amžius nuo 18 iki 69 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
Renkami dalyviai3 fazė
Amžius nuo 1 iki 25 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 35 · Visoms lytims · Atnaujinta 2026-09-11 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
Renkami dalyviai2 fazė
Amžius nuo 4 iki 34 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
Renkami dalyviai2 fazė
Amžius nuo 8 iki 45 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Renkami dalyviai1/2 fazė
Amžius nuo 9 iki 20 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
Renkami dalyviai2 fazė
Amžius nuo 5 iki 40 · Visoms lytims · Atnaujinta 2026-08-24 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-16 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-02 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-14 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-09 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-04-06 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-24 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Renkami dalyviai3 fazė
Amžius nuo 18 iki 49 · Visoms lytims · Atnaujinta 2026-03-04 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Renkami dalyviai
Amžius nuo 16 iki 19 · Visoms lytims · Atnaujinta 2025-12-30 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
Renkami dalyviaiStebimasis tyrimas
Iki 70 metų · Visoms lytims · Atnaujinta 2025-12-19 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Renkami dalyviai
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2025-12-16 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 2 iki 45 · Visoms lytims · Atnaujinta 2025-07-01 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Renkami dalyviai1 fazė
Amžius nuo 12 iki 25 · Visoms lytims · Atnaujinta 2025-06-13 · NCT05065372Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.